We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Johnson & Johnson Aims To Regain Remicade Rights

Law360 (May 21, 2009, 12:00 AM EDT) -- Johnson & Johnson plans to head to arbitration to seek the return of its full rights to market and sell arthritis treatment Remicade from Schering-Plough Corp. now that Merck & Co....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.